News | AP VALVES & SH 2021 Virtual

Data Hints at TAVR Expansion Into Low-risk Bicuspid AS but RCTs on Risky Morphology Still Missing

[AP VALVES & SH 2021] Cardiologists call for randomized trials defining morphology for positive TAVR outcomes in low surgical risk patients with bicuspid aortic stenosis

August 06, 2021 20529 0 Read More

News | AP VALVES & SH 2021 Virtual

4 Upcoming and Novel LAAO Devices and Best Multimodal Imaging for Challenging Cases

[AP VALVES & SH 2021] Philippe Garot, MD looks at pre-clinical devices touted to help positioning/sizing and mitigate LAAO procedure risk with complex anatomy

August 06, 2021 13382 0 Read More

News | AP VALVES & SH 2021 Virtual

Upfront Protection Needed for 'Rare But Real' Risk of TAVR-related Coronary Artery Occlusion

[AP VALVES & SH 2021] Expert highlights when and how to protect at-risk arteries for TAVR patients

August 05, 2021 6813 0 Read More

News | AP VALVES & SH 2021 Virtual

Evolut or Sapien? Expert Unravels 'Equation' for Choosing TAVR Device

[AP VALVES & SH 2021] BEV/SEV experience, proper technique, detailed patient assessment highlighted as critical factors for optimal TAVR outcomes

August 05, 2021 18001 0 Read More

News | SummitMD

FLOWER-MI: FFR Shows No Benefit over Angio for Complete Revasc in Multi-vessel STEMIs

Findings say FFR-guided PCI not superior (or cost-effective) compared to angio-guided PCI, although experts warn results may not be conclusive

July 21, 2021 12094 0 Read More

News | SummitMD

'Next-Gen' ADAPTABLE Study Says Low-Dose Aspirin Equal to High-Dose for ASCVD Patients

High-tech, low-cost study reflects real-world data and finds 81mg aspirin superior, although critics say high switching rate impacts reliability of findings

July 05, 2021 2881 0 Read More

News | SummitMD

In DES-PCI Era, Clopidogrel Gains Traction over Aspirin as Maintenance Monotherapy after DAPT

HOST-EXAM reports post-DAPT clopidogrel monotherapy drops ischemic and bleeding events by 30% in Korean population

June 21, 2021 8768 0 Read More